Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Short H2A histone variants are expressed in cancer.

Tytuł:
Short H2A histone variants are expressed in cancer.
Autorzy:
Chew GL; The Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Bleakley M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Bradley RK; Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Malik HS; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Henikoff S; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Molaro A; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. .; Genetics, Reproduction and Development (GReD) Institute, Université Clermont Auvergne, Clermont-Ferrand, France. .
Sarthy J; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. .
Źródło:
Nature communications [Nat Commun] 2021 Jan 20; Vol. 12 (1), pp. 490. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [London] : Nature Pub. Group
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Histones/*genetics
Histones/*metabolism
Neoplasms/*genetics
Neoplasms/*metabolism
Alternative Splicing ; Animals ; Chromatin ; Epigenomics ; Female ; Genomics ; Humans ; Nucleosomes ; Placenta ; Pregnancy ; Up-Regulation
References:
BMC Mol Cell Biol. 2020 Jul 20;21(1):55. (PMID: 32690000)
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W509-12. (PMID: 18463140)
Mol Oncol. 2011 Apr;5(2):164-82. (PMID: 21376678)
Nature. 2019 Apr;568(7753):511-516. (PMID: 30971826)
RNA. 2019 Jul;25(7):813-824. (PMID: 30988101)
Bioinformatics. 2009 May 1;25(9):1105-11. (PMID: 19289445)
Cancer Discov. 2019 Oct;9(10):1438-1451. (PMID: 31337617)
J Biochem. 2018 Feb 1;163(2):97-103. (PMID: 29165574)
Nucleic Acids Res. 2016 May 5;44(8):e71. (PMID: 26704973)
PLoS Genet. 2017 Feb 24;13(2):e1006633. (PMID: 28234895)
Nucleic Acids Res. 2018 Nov 2;46(19):10007-10018. (PMID: 30053102)
Nat Med. 2018 May;24(5):679-690. (PMID: 29713087)
Nature. 2012 Mar 28;483(7391):603-7. (PMID: 22460905)
Nat Commun. 2016 Jun 06;7:11790. (PMID: 27265895)
Genome Biol. 2009;10(3):R25. (PMID: 19261174)
Nature. 2019 Mar;567(7749):473-478. (PMID: 30894748)
Science. 2013 May 17;340(6134):857-61. (PMID: 23539183)
Nat Biotechnol. 2013 Mar;31(3):213-9. (PMID: 23396013)
Epigenetics Chromatin. 2020 Jul 14;13(1):28. (PMID: 32664941)
Genome Biol. 2019 Jan 31;20(1):23. (PMID: 30704500)
Blood. 2017 Nov 16;130(20):2204-2214. (PMID: 28855157)
Protein Sci. 2003 May;12(5):1007-17. (PMID: 12717023)
Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14840-5. (PMID: 26578803)
Mol Cell. 2012 Aug 24;47(4):596-607. (PMID: 22795134)
Nat Genet. 2016 May;48(5):569-74. (PMID: 27019113)
Annu Rev Pharmacol Toxicol. 2014;54:251-72. (PMID: 24160706)
Genome Res. 2017 Feb;27(2):185-195. (PMID: 27903646)
Biophys J. 2021 Apr 20;120(8):1498-1509. (PMID: 33609493)
Nature. 2015 Jul 2;523(7558):96-100. (PMID: 25970242)
Nat Methods. 2010 Dec;7(12):1009-15. (PMID: 21057496)
Genome Biol. 2010;11(3):R25. (PMID: 20196867)
Nucleic Acids Res. 2019 Jul 9;47(12):6145-6159. (PMID: 31076740)
Trends Cancer. 2019 Mar;5(3):183-194. (PMID: 30898265)
Nucleic Acids Res. 2013 Jan;41(Database issue):D48-55. (PMID: 23203987)
BMC Bioinformatics. 2011 Aug 04;12:323. (PMID: 21816040)
Nat Rev Cancer. 2016 Jul;16(7):413-30. (PMID: 27282250)
Cells. 2020 Apr 02;9(4):. (PMID: 32252453)
J Cell Biol. 2007 Jan 29;176(3):283-94. (PMID: 17261847)
EMBO J. 2004 Aug 18;23(16):3314-24. (PMID: 15257289)
Science. 2018 Oct 26;362(6413):. (PMID: 30361341)
Sci Adv. 2019 Jul 03;5(7):eaax2887. (PMID: 31281901)
EBioMedicine. 2016 Jun;8:173-183. (PMID: 27428428)
Nucleic Acids Res. 2013 Jan;41(Database issue):D64-9. (PMID: 23155063)
Nucleic Acids Res. 2014 Jun;42(10):6405-20. (PMID: 24753410)
Cancer Immunol Immunother. 2012 Oct;61(10):1769-79. (PMID: 22419371)
Nat Methods. 2015 Feb;12(2):115-21. (PMID: 25633503)
Nature. 1997 Sep 18;389(6648):251-60. (PMID: 9305837)
Genome Res. 2018 Apr;28(4):460-473. (PMID: 29549088)
Nat Genet. 2020 Jan;52(1):84-94. (PMID: 31911676)
EMBO J. 2006 Sep 20;25(18):4234-44. (PMID: 16957777)
Nat Struct Mol Biol. 2011 Dec 04;19(1):25-30. (PMID: 22139013)
Curr Opin Struct Biol. 2015 Jun;32:48-57. (PMID: 25731851)
Database (Oxford). 2016 Mar 17;2016:. (PMID: 26989147)
Elife. 2017 Dec 18;6:. (PMID: 29251591)
Nat Commun. 2019 May 13;10(1):2146. (PMID: 31086175)
Sci Rep. 2019 Oct 2;9(1):14184. (PMID: 31578439)
Grant Information:
R01 GM074108 United States GM NIGMS NIH HHS; United States HHMI Howard Hughes Medical Institute
Substance Nomenclature:
0 (Chromatin)
0 (Histones)
0 (Nucleosomes)
Entry Date(s):
Date Created: 20210121 Date Completed: 20210201 Latest Revision: 20240330
Update Code:
20240330
PubMed Central ID:
PMC7817690
DOI:
10.1038/s41467-020-20707-x
PMID:
33473122
Czasopismo naukowe
Short H2A (sH2A) histone variants are primarily expressed in the testes of placental mammals. Their incorporation into chromatin is associated with nucleosome destabilization and modulation of alternate splicing. Here, we show that sH2As innately possess features similar to recurrent oncohistone mutations associated with nucleosome instability. Through analyses of existing cancer genomics datasets, we find aberrant sH2A upregulation in a broad array of cancers, which manifest splicing patterns consistent with global nucleosome destabilization. We posit that short H2As are a class of "ready-made" oncohistones, whose inappropriate expression contributes to chromatin dysfunction in cancer.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies